Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search

		Submit


Tuberculosis (TB)


Facebook
        Twitter
        LinkedIn
        Syndicate





2018 State and City TB Report										Related Pages
										Return to Main Menu
		On This Page
			Overall TB Incidence, U.S.TB Incidence, U.S.-born PersonsTB Incidence, Non-U.S.–born PersonsTB incidence, U.S.-born Non-Hispanic Blacks or African AmericansFootnotes
		
**Incidence1**
Elimination of TB is defined as reducing TB disease incidence in the United States to less than 1 case per million persons per year. Therefore, measuring the number of new cases occurring each year remains the best overall indicator of progress toward TB elimination. In 2018, overall TB incidence in the United States was 2.8 TB cases (including U.S.-born and non-U.S.–born persons) per 100,000 persons (28 cases per million). Overall, TB incidence remained the same from 2017 to 2018; however, the nation has not yet achieved the 2025 national target of <1.3 TB cases per 100,000 (Figure 1image icon, Figure 2image icon, Footnotes).




**Overall TB Incidence in the United States, 2018**
In 2018, 42 states and 1 city reported incidences at or below the national average of 2.8 cases per 100,000 (including U.S.-born and non-U.S.-born persons). Incidences in 8 states and 8 cities were above the national average.
States/cities are grouped into thirds based on numbers of TB cases reported in 2018.Figure1Figure 1: Overall TB Incidence in the United States, 2018
resize iconView Larger
CloseFigure1Figure 1: Overall TB Incidence in the United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]Figure2Figure 2: Overall TB Incidence in the United States, 2018
resize iconView Larger
CloseFigure2Figure 2: Overall TB Incidence in the United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]**TB Incidence Among U.S.-born Persons in the United States, 2018**
In 2018, a total of 14 states met the 2025 national target of 0.4 cases per 100,000 U.S.-born persons; 18 states were short of the 2025 target, but reported incidences at or below the national average of 0.9 cases per 100,000 U.S.-born persons.  Sixteen states and all selected cities were above the national average of 0.9 cases per 100,000 U.S.-born persons.
States/cities are grouped into thirds based on numbers of TB cases reported in 2018.Figure3Figure 3: TB Incidence Among U.S.-born Persons in the United States, 2018
resize iconView Larger
CloseFigure3Figure 3: TB Incidence Among U.S.-born Persons in the United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]Figure4Figure 4: TB Incidence Among U.S.-born Persons in the United States, 2018
resize iconView Larger
CloseFigure4Figure 4: TB Incidence Among U.S.-born Persons in the United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]**TB Incidence Among Non-U.S.–born Persons in the United States, 2018**
In 2018,  a total of 6 states met the 2025  target of 8.8 cases per 100,000 non-U.S.-born persons;  17 states and 2 cities were short  of the 2025  target, but still reported incidences at or below the national average of 14.3 cases per 100,000 non-U.S.-born  persons.  The remaining 25 states and 7 cities were above the 2025 target and national average.
States/cities are grouped into thirds based on numbers of TB cases reported in 2018.Figure5Figure 5: TB Incidence Among Non-U.S.–born Persons in the United States, 2018
resize iconView Larger
CloseFigure5Figure 5: TB Incidence Among Non-U.S.–born Persons in the United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]Figure6Figure 6: TB Incidence Among Non-U.S.–born Persons in the United States, 2018
resize iconView Larger
CloseFigure6Figure 6: TB Incidence Among Non-U.S.–born Persons in the United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]**TB Incidence Among U.S.-born Non-Hispanic Blacks or African Americans, United States, 2018**
In 2018, 5 states met the 2025 national target of 1.0 cases per 100,000 U.S.-born non-Hispanic black persons; 23 states and 3 cities were short of the 2025 target, but reported incidences at or below the national average of 2.6 cases per 100,000 U.S.-born non-Hispanic black persons.  Ten states and 6 cities reported incidences above the 2025 target and national average.  Twelve states did not report any cases of TB among U.S.-born non-Hispanic black persons.
States/cities are grouped into thirds based on numbers of TB cases reported in 2018.Figure5Figure 7: TB Incidence Among U.S.-born Non-Hispanic Blacks or African Americans, United States, 2018
resize iconView Larger
CloseFigure5Figure 7: TB Incidence Among U.S.-born Non-Hispanic Blacks or African Americans, United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]Figure8Figure 8: TB Incidence Among U.S.-born Non-Hispanic Blacks or African Americans, United States, 2018
resize iconView Larger
CloseFigure8Figure 8: TB Incidence Among U.S.-born Non-Hispanic Blacks or African Americans, United States, 2018
download iconDownload Imageimage icon[PNG, NAN ]Footnotes1Centers for Disease Control and Prevention (CDC). *Reported Tuberculosis in the United States, 2018*. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/tb/statistics/reports/2018/default.htm
**Figures 1 and 2: Overall TB Incidence*, United States, 2018**
Data source: National Tuberculosis Surveillance System as of June 6, 2019; population data from the U.S. Census Bureau’s American Community Survey, 2017.
*Numbers of TB cases per 100,000 persons
**Figures 3 and 4: TB Incidence,* U.S.-born Persons, United States, 2018**
Data source: National Tuberculosis Surveillance System as of June 6, 2019; population data from the U.S. Census Bureau’s American Community Survey, 2017.
*Numbers of TB cases per 100,000 U.S.-born persons
**Figures 5 and 6: TB Incidence,* Non-U.S.–born Persons, United States, 2018**
Data source: National Tuberculosis Surveillance System as of June 6, 2019; population data from the U.S. Census Bureau’s American Community Survey, 2017.
*Numbers of TB cases per 100,000 non-U.S.-born persons
**Figures 7 and 8: TB Incidence,* U.S.-born Non-Hispanic Blacks or African Americans, United States, 2018**
Data source: National Tuberculosis Surveillance System as of June 6, 2019; population data from the U.S. Census Bureau’s American Community Survey, 2017.
*Numbers of TB cases per 100,000 U.S.-born non-Hispanic black persons
							
					
						Page last reviewed:  March 9, 2020					Content source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue